Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients

Matt S. Zinter(UCSF Benioff Children's Hospital), Christopher C. Dvorak(University of California, San Francisco), Kasiani C. Myers(Immune Deficiency Foundation), Mohamed L. Sorror(University of Washington Medical Center), Seth J. Rotz(Cleveland Clinic), Robert J. Hayashi(Washington University in St. Louis), Joelle Strom(Medical College of Wisconsin), Satiro De Oliveira(University of California, Los Angeles), Greg Guilcher(Lurie Children's Hospital), Amer Beitinjaneh(University of Miami), Dimana Dimitrova(National Institutes of Health), Peiman Hematti(UW Health University Hospital), Lena E. Winestone(University of California, San Francisco), Sagar S. Patel(University of Utah), Stella Chen(Baylor Genetics), Stephanie Bo‐Subait(National Marrow Donor Program), Neel S. Bhatt(The Ohio State University Wexner Medical Center), Betty K. Hamilton(Cleveland Clinic), David Buchbinder(Children's Hospital of Orange County), Taiga Nishihori(Moffitt Cancer Center), Sherif M. Badawy(Northwestern University), Ruta Brazauskas(Medical College of Wisconsin), Akshay Sharma(St. Jude Children's Research Hospital), Jaime M. Preussler(National Marrow Donor Program), Bipin N. Savani(Vanderbilt University Medical Center), Rachel Phelan(Children's Hospital of Wisconsin), Hélène Schoemans(KU Leuven), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Olle Ringdén(Karolinska Institutet)
medRxiv
August 5, 2023
Cited by 3


Related Papers